鼻窦未分化癌选择性颈部治疗的系统综述与荟萃分析
该系统综述与荟萃分析纳入12项研究共255例临床N0鼻窦未分化癌患者,评估选择性颈部治疗对区域复发的影响。
要点
- SNUC患者区域失败风险不容忽视,观察组区域复发率达26.4%。
- 临床N0的SNUC患者可考虑行选择性颈部治疗以降低区域复发。
核心结论
- 荟萃分析表明选择性颈部治疗可显著降低SNUC患者的区域复发风险。
研究设计与样本
- 系统综述与荟萃分析,纳入1999至2019年发表的12项研究,共255例患者临床数据。
主要发现
- 83.4%的患者为T4肿瘤,14.1%存在颈部淋巴结阳性。
- 49.5%的分析患者接受了选择性颈部治疗。
- 选择性颈部治疗组区域复发率为3.7%,未治疗组为26.4%。
临床怎么用
- 对临床N0的SNUC患者,可考虑行选择性颈部治疗以降低区域复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sinonasal undifferentiated carcinomas (SNUCs), being an aggressive malignancy with dismal survival outcome, have given limited consideration regarding management of regional failures. A total of 12 studies, published between 1999 and 2019, met inclusion criteria. We performed a meta-analysis assessing regional (neck) relapse after elective neck treatment compared to observation in clinically node negative (N0) necks. Clinical data of 255 patients were used for meta-analysis. Among them, 83.4% of patients presented with T4 tumors and 14.1% had positive neck nodes. Elective neck treatment was applied in 49.5% of analyzed patients. Regional relapses occurred in 3.7% of patients who have undergone elective neck treatment compared to 26.4% in patients who had not. Elective neck treatment significantly reduced the risk of regional recurrence (odds ratio 0.20; 95% confidence interval 0.08-0.49; P = .0004). The meta-analysis indicates that elective neck treatment could significantly reduce the risk of regional failures in patients with SNUCs.
引用
- Faisal M, Seemann R, Lill C, et al. Elective neck treatment in sinonasal undifferentiated carcinoma: Systematic review and meta-analysis. Head Neck. 2020. PMID: 31922316. doi:10.1002/hed.26077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。